$14.24
0.00 (0%)
King Pharmaceuticals, Inc. (NYSE:KG)
CAPS Rating:
The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.
RSS Headlines
Fool UK